نتایج جستجو برای: coagulation factor viii gene

تعداد نتایج: 1848603  

Journal: :iranian journal of pediatric hematology and oncology 0
fatemeh sarkargar phd student of biochemistry, department of biology, faculty of science, payamnoor -university, tehran, ira mahta mazaheri associate professor of medical genetics (md-phd), department of genetics, faculty of medicine, shahid sadoughi universiسازمان های دیگر: mother and newborn health research center, shahid sadoughi university of medical science, yazd, iran hossein khodai expert laboratory of genetic, meybod genetic research center, meybod, iranسازمان اصلی تایید شده: دانشگاه پیام نور تهران (payame noor university) razieh sadat tabatabaei assistant professor of gynecology, department of gynecology and obstetrics, faculty of medicine, shahid sadoughi universسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences)

background: haemophilia a (ha) is an x-linked bleeding disorder caused by the absence or reduced activity of coagulation factor viii (fviii). coagulation factors are a group of related proteins that are essential for the formation of blood clots. the aim of this study was to genotype the coagulation factor viii gene mutations using inverse shifting pcr (is-pcr) in an iranian family with severe ...

ALI AKBAR POURFATHOLLAH, HABIBOLLAH ESMAILI, HASSAN MANSOURI TORGHABEH, MAHMOOD MAHMOODIAN SHOOSHTARI, ZAHRA REZAIE YAZDI,

Patients with coagulation factor(s) deficiency who use coagulation therapy are susceptible to forming inhibitors against coagulation factor(s). In this survey we detected factor V and VIII inhibitor in ten patients with combined deficiency of factors V and VIII from north east of Iran (Khorassan province). It was revealed in our survey that eight patients had both factor V and factor VIII i...

Journal: :medical journal of islamic republic of iran 0
hassan mansouri torghabeh from the 'experimental hematology and blood banking dept, medical sciences school, tarbiat modaresuniversity (t.m. u.), ali akbar pourfathollah from the 'experimental hematology and blood banking dept, medical sciences school, tarbiat modaresuniversity (t.m. u.), mahmood mahmoodian shooshtari the iranian blood transfusion organization research center, tehran zahra rezaie yazdi the departmentof internal medicine, mashhad medical sciences university, mashhad habibollah esmaili 4community medicine and public health department of mashhad medical sciences university, mashhad, iran

patients with coagulation factor(s) deficiency who use coagulation therapy are susceptible to forming inhibitors against coagulation factor(s). in this survey we detected factor v and viii inhibitor in ten patients with combined deficiency of factors v and viii from north east of iran (khorassan province). it was revealed in our survey that eight patients had both factor v and factor viii inhib...

Fatemeh Sarkargar, Hossein Khodai , Mahta Mazaheri , Razieh Sadat Tabatabaei,

Abstract Background: Haemophilia A (HA) is an X-linked bleeding disorder caused by the absence or reduced activity of coagulation factor VIII (FVIII). Coagulation factors are a group of related proteins that are essential for the formation of blood clots. The aim of this study was to genotype the coagulation factor VIII gene mutations using Inverse Shifting PCR (IS-PCR) in an Iranian family ...

Journal: :arya atherosclerosis 0
s asgary a poorshams gh naderi ah siadat n askari

abstract  introduction: during extrinsic coagulation pathway, a complex is developed between factor vii, calcium and tissue factor (a cell membrane lipoprotein that is exposed after cell injury). factor vii needs calcium and vitamin k for its biologic activation. coronary artery disease (cad) can be induced by increased level and activity of the coagulation factors vii, viii and ix. in postmeno...

Journal: :The Ulster Medical Journal 1993
P. C. Winter E. E. Butler

The gene for the coagulation protein factor VIII contains several common restriction fragment length polymorphisms which can be used to analyse the pattern of inheritance of factor VIII alleles within families. This can be exploited to identify carriers of haemophilia, an X-linked inherited disorder characterised by deficiency of factor VIII. In this study the polymerase chain reaction was used...

ذوالفقاری, سیما , صادقی, معصومه , عسکری, نازیلا , عسگری, صدیقه , فاضلی, مریم , نادری, غلامعلی, پورشمس, اکرم ,

Background: During extrinsic coagulation pathway, a complex is developed between factor VII, calcium and tissue factor (a cell membrane lipoprotein that is exposed after cell injury). Factor VII needs calcium and vitamin K for its biologic activation. Coronary artery disease can be induced by increased level and activity of the coagulation factors VII, VIII and IX. In postmenopausal period, est...

2012
Yuji Kashiwakura Jun Mimuro Akira Onishi Masaki Iwamoto Seiji Madoiwa Daiichiro Fuchimoto Shunichi Suzuki Misae Suzuki Shoichiro Sembon Akira Ishiwata Atsushi Yasumoto Asuka Sakata Tsukasa Ohmori Michiko Hashimoto Satoko Yazaki Yoichi Sakata

Hemophilia A is a common X chromosome-linked genetic bleeding disorder caused by abnormalities in the coagulation factor VIII gene (F8). Hemophilia A patients suffer from a bleeding diathesis, such as life-threatening bleeding in the brain and harmful bleeding in joints and muscles. Because it could potentially be cured by gene therapy, subhuman animal models have been sought. Current mouse hem...

2005
Catherine Driscoll Eric Bouhassira Louis M. Aledort

Hemophilia B is an X-Iinked recessive bleeding disorder resulting from a deficiency of the coagulation factor IX (FIX) protein activity. a vitamin K-dependent serine protease active in both the intrinsic and extrinsic coagulation systems. DNA analyses of the factor IX gene in two unrelated patients with severe hemophilia B. with a IX coagulant activity <1 % and undetectable FIX antigen. detecte...

Journal: :Haemostasis 1989
M Xi S Béguin H C Hemker

We report a study on the importance of factor IX activation in thromboplastin-dependent coagulation in plasma. Diluted, CaCl2-containing thromboplastin solutions at constant phospholipid concentration were used to trigger the coagulation in plasma from patients with congenital factor IX and factor VIII deficiency in the presence and absence of added factors IX and VIII, and the generation of th...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید